MOTS-c discussions are framed inside a broader metabolic strategy that may include lab testing, lifestyle calibration, and other supportive therapies
Clinical trial results Phase 2 trial data published in the New England Journal of Medicine showed that participants receiving the highest dose of retatrutide (12mg weekly) achieved 24.2% body weight reduction over 48 weeks
Its primary role is to help protect cells from damage caused by free radicals and oxidative stress
2.3 Recommended Dosage for Other Indications in Adults The recommended dosage of FARXIGA is 10 mg orally once daily in adults for the following indications: To reduce the risk of sustained eGFR decline, end-stage kidney disease (ESKD), CV death, and hospitalization for heart failure (hHF) in patients with chronic kidney disease at risk of progression
Moeller SM, Taylor A, Tucker KL, McCullough ML, Chylack LT, Hankinson SE, et al